The ratio of CD8+ T cells versus Treg cells, a key prognostic factor for cancer, increased in the treated tumors, with a significant increase in levels on both 9 and 15 DPT, with 1.16 times increase in the αCSF1R group compared to the control group (Figure 2G). This evidence concerns the gene CD8A and cancer.